Move data. Preserve meaning. Prove the exchange.
The living guidance adds implementation context for impacted payers preparing Provider Access, Payer-to-Payer, Prior Authorization, and expanded Patient Access APIs.
The national brief shows broad public-health connectivity while documenting the operating services and remaining barriers hidden behind a simple connection count.
The approval creates a newer voluntary path for certified health IT, but it does not replace the USCDI v3 baseline required under HTI-1.
The national brief shows broad public-health connectivity while documenting the operating services and remaining barriers hidden behind a simple connection count.
The approval creates a newer voluntary path for certified health IT, but it does not replace the USCDI v3 baseline required under HTI-1.
The milestone establishes material network activity, while the accompanying oversight actions make participation quality and governance more important than raw volume.
The release keeps document exchange current and underscores why enterprise programs must manage FHIR resources and CDA documents as different artifacts.
The guide advances U.S. profiles without changing the underlying fact that major domestic implementation remains anchored to FHIR R4.
The final rule establishes a federal TEFCA regulatory part while leaving unfinalized proposals withdrawn, a distinction current summaries must preserve.
TEFCA designation, network participation, exchange purpose, technical route, and local production reach are separate facts. The market map keeps organizational role and evidence class visible.
Read the market record →FHIR version, profile, authorization pattern, terminology, endpoint behavior, testing, and ongoing operations must be evaluated together; a generic FHIR claim cannot answer those questions.
Read the market record →Patient matching, provenance, vocabulary normalization, consent, and data-quality controls determine whether transported data can be trusted and used in the receiving workflow.
Read the market record →Routing, authorization, monitoring, exception handling, change control, endpoint discovery, support ownership, and recovery determine whether exchange remains usable after implementation.
Read the market record →Readiness records should be separated by API, implementation guide, source system, responsible party, test status, production status, and exception process.
Provider records should distinguish public-health connection from bidirectional production use, data quality, identity services, and operating support.
Developers and buyers need separate records for the mandatory baseline, voluntarily advanced version, and version actually deployed in a customer environment.
TEFCA has become a material exchange channel, but buyers still need organization-specific evidence for reach, exchange purpose, data quality, operating performance, and governance.
Enterprise exchange programs need explicit document-ingestion, validation, reconciliation, and extraction evidence in addition to FHIR API capability.
FHIR platform and integration claims should identify both the base FHIR release and the exact US Core guide version, supported profiles, tests, and production status.
The research connects the provider market, normalized capabilities, authority records, operating domains, and source limitations rather than presenting a score or universal winner.
Read the report →